Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-14-014041
Filing Date
2014-02-27
Accepted
2014-02-27 12:24:16
Documents
1
Group Members
BB BIOTECH VENTURES G.P. (GUERNSEY) LIMITED.BEN MORGANJAN BOOTSMAMARTIN MUENCHBACHPASCAL MAHIEUX

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a14-6857_1sc13da.htm SC 13D/A 303732
  Complete submission text file 0001104659-14-014041.txt   305601
Mailing Address ATTN: CHIEF FINANCIAL OFFICER 201 BROADWAY, 6TH FLOOR CAMBRIDGE MA 02139
Business Address ATTN: CHIEF FINANCIAL OFFICER 201 BROADWAY, 6TH FLOOR CAMBRIDGE MA 02139 617 425 9225
Radius Health, Inc. (Subject) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-84055 | Film No.: 14647583
SIC: 6770 Blank Checks

Mailing Address TRAFALGAR COURT, LES BANQUES ST. PETER PORT GUERNSEY Y7 GY1 3QL
Business Address TRAFALGAR COURT, LES BANQUES ST. PETER PORT GUERNSEY Y7 GY1 3QL 44 0 1481 745-001
BB Biotech Ventures II, L.P. (Filed by) CIK: 0001522015 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 1231
Type: SC 13D/A